![](/img/cover-not-exists.png)
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone
Wasan, H S, Springett, G M, Chodkiewicz, C, Wong, R, Maurel, J, Barone, C, Rosbrook, B, Ricart, A D, Kim, S, Spano, J-PVolume:
101
Year:
2009
Language:
english
Pages:
6
DOI:
10.1038/sj.bjc.6605243
File:
PDF, 196 KB
english, 2009